23 July 2011

Prof. (Dr.) Kh. Abdul Awal (Rizvi)

The Director and Professor
NITOR, Shyamoli
Dhaka.

Subject: To organize a Launching Program of Febux 40(Febuxostat) at NITOR

Dear Sir,

You are well aware that Febuxostat is the first agent marketed in the United
States to treat hyperuricemia of gout since 1964. We take the pleasure to inform you that
MonicoPharma has planned to launch this product in Bangladesh for the benefit of the
patients who are suffering from gout or chronic arthritis attack.

NITOR is the key opinion organization in related field. To promote the benefits
as well as product, we would like to organize a Launching Program in NITOR in the form
of a Seminar where all Doctors of NITOR will be invited to pass their opinion on this.
As discussed, I would highly appreciate if you kindly allow us to organize the
said Launching Program in your organization at your convenience. Look forward to your
kind cooperation.

Thanking you.

Best regards.

Sazzadul Bari M.Pharm

Director & CEO
MonicoPharma Limited